Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Clinical trial NCT04631601 · TERMINATED
Trial details
- NCT number
- NCT04631601
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2023-10-23
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.